Aug 23 (Reuters) - Eli Lilly's (LLY.N), opens new tab treatment for early Alzheimer's is expected to be blocked for use by Britain's National Health Service (NHS), the Telegraph reported on Frida
INDIANAPOLIS, Aug. 22, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024. Jacob Van Naarden, executive vice president and president, Lilly Oncology, will participate in a fireside chat at 7:45 a.m. Eastern time.
STOCKHOLM, Aug. 22, 2024 /PRNewswire/ -- Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce that they have entered into a research collaboration agreement with Eli Lilly and Company (Lilly) to apply the AbiProt® technology to generate antibodies to a high-value target. This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties.
Novo Nordisk and Eli Lilly Likely to maintain clout in GLP-1R market
Lilly’s Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Overweight, Obese Adults
After picking up the European rights to Eli Lilly’s Emgality and Rayvow late last year, women’s health outfit Organon is upping its migraine accord with the Big Pharma company.
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
Lilly Catalyze360 looks to connect with emerging biotechs across `all areas`
Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Suppl Approvals in US
Lilly Completes $3.2B Acquisition of Morphic